JAK1 and Alzheimer disease: TYK2 encodes a member of the tyrosine kinase specifically for the Janus kinases (JAKs) protein families, and inhibition of JAK1/JAK3 may provide an efficient therapeutic agent for the treatment of inflammatory diseases33 which might benefit AD patients as well since inflammation drives progression of AD34.